Christopher Coldren
Last active: 10/17/2012

Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

Aldred MA, Comhair SA, Varella-Garcia M, Asosingh K, Xu W, Noon GP, Thistlethwaite PA, Tuder RM, Erzurum SC, Geraci MW, Coldren CD
Am J Respir Crit Care Med. 2010 182 (9): 1153-60

PMID: 20581168 · PMCID: PMC3001257 · DOI:10.1164/rccm.201003-0491OC

RATIONALE - Vascular remodeling in pulmonary arterial hypertension (PAH) involves proliferation and migration of endothelial and smooth muscle cells, leading to obliterative vascular lesions. Previous studies have indicated that the endothelial cell proliferation is quasineoplastic, with evidence of monoclonality and instability of short DNA microsatellite sequences.

OBJECTIVES - To assess whether there is larger-scale genomic instability.

METHODS - We performed genome-wide microarray copy number analysis on pulmonary artery endothelial cells and smooth muscle cells isolated from the lungs of patients with PAH.

MEASUREMENTS AND MAIN RESULTS - Mosaic chromosomal abnormalities were detected in PAEC cultures from five of nine PAH lungs but not in normal (n = 8) or disease control subjects (n = 5). Fluorescent in situ hybridization analysis confirmed the presence of these abnormalities in vivo in two of three cases. One patient harbored a germline mutation of BMPR2, the primary genetic cause of PAH, and somatic loss of chromosome-13, which constitutes a second hit in the same pathway by deleting Smad-8. In two female subjects with mosaic loss of the X chromosome, methylation analysis showed that the active X was deleted. One subject also showed completely skewed X-inactivation in the nondeleted cells, suggesting the pulmonary artery endothelial cell population was clonal before the acquisition of the chromosome abnormality.

CONCLUSIONS - Our data indicate a high frequency of genetically abnormal subclones within PAH lung vessels and provide the first definitive evidence of a second genetic hit in a patient with a germline BMPR2 mutation. We propose that these chromosome abnormalities may confer a growth advantage and thus contribute to the progression of PAH.

MeSH Terms (25)

Adult Airway Remodeling Bone Morphogenetic Protein Receptors, Type II Cell Proliferation Child Chromosome Aberrations Chromosome Deletion DNA Copy Number Variations Endothelial Cells Female Gene Rearrangement Genome-Wide Association Study Genomic Instability Germ-Line Mutation Humans Hypertension, Pulmonary In Situ Hybridization, Fluorescence Lung Microarray Analysis Middle Aged Myocytes, Smooth Muscle Polymorphism, Single Nucleotide Pulmonary Artery Pulmonary Disease, Chronic Obstructive X Chromosome Inactivation

Connections (1)

This publication is referenced by other Labnodes entities:

Links